サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1413223

ホスホロアミダイト市場：タイプ別、エンドユーザー別-2024-2030年の世界予測

Phosphoramidite Market by Type (DNA Phosphoramidites, Dye-Labeled Phosphoramidites, RNA Phosphoramidites), End-User (Academic & Research Institutions, Contract Research Organizations, Pharmaceutical & Biotechnology) - Global Forecast 2024-2030
出版日: | 発行: 360iResearch | ページ情報: 英文 190 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
ホスホロアミダイト市場：タイプ別、エンドユーザー別-2024-2030年の世界予測
出版日: 2024年01月15日
発行: 360iResearch
ページ情報: 英文 190 Pages
納期: 即日から翌営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

ホスホロアミダイト市場規模は2023年に12億8,000万米ドルと推計され、2024年には13億8,000万米ドルに達し、CAGR 7.49%で2030年には21億3,000万米ドルに達すると予測されます。

ホスホロアミダイトの世界市場

主な市場の統計
基準年[2023］ 12億8,000万米ドル
予測年[2024］ 13億8,000万米ドル
予測年 [2030] 21億3,000万米ドル
CAGR（%） 7.49%
ホスホロアミダイト Market-IMG1

ホスホロアミダイトは、固相オリゴヌクレオチド合成においてDNAやRNAなどの核酸を合成するために一般的に使用される化合物の一種です。ホスホロアミダイトは、窒素原子を介してアミノ基に結合したリン原子と、反応性を制御するための様々な保護基を含む有機リン化合物です。ハイスループット塩基配列決定技術の登場によるゲノミクス研究の活発化と、大規模な遺伝子情報の調査ニーズが、ホスホロアミダイトの利用を拡大しています。個人の遺伝子構成に基づいたオーダーメイドのヘルスケアソリューションの提供を目指す個別化医療への注目の高まりが、ホスホロアミダイトの需要を高めています。ホスホロアミダイトに関連する高コストとスケーラビリティが市場の成長を妨げます。合成法とホスホロアミダイト技術の絶え間ない進歩は、効率、収率、費用対効果を改善する機会を提供します。

地域別の洞察

特に米国とカナダでは、製薬およびバイオテクノロジー産業が確立しており、核酸ベースの治療薬や研究ツールの合成に不可欠な構成要素として、ホスホロアミダイトの需要を牽引しています。米国のFDAを含む規制機関は、核酸ベースの治療薬の開発にガイドラインとサポートを提供しており、これがこの地域でのホスホロアミダイトの採用を促進し、市場の成長を促しています。個人の遺伝情報に基づき、オーダーメイドのヘルスケアソリューションを提供することを目的とした個別化医療への取り組みが増加しており、EMEA市場におけるホスホロアミダイトメーカーにビジネスチャンスをもたらすと期待されています。アジア太平洋地域の政府は、さまざまな取り組みや資金提供プログラムを通じて、バイオテクノロジーやライフサイエンス分野の発展を積極的に支援しています。例えば、中国はバイオテクノロジーを含む先端製造業の発展を促進するために「メイド・イン・チャイナ2025」構想を打ち出しました。政府の支援と資金援助は研究開発活動を促進し、ホスホロアミダイトメーカーが協力して市場の成長に貢献する機会を創出しています。

FPNVポジショニング・マトリックス

FPNVポジショニングマトリックスはホスホロアミダイト市場を評価する上で極めて重要です。事業戦略や製品満足度に関連する主要指標を調査し、ベンダーの包括的な評価を提供します。この綿密な分析により、ユーザーは各自の要件に沿った十分な情報に基づいた意思決定を行うことができます。評価に基づき、ベンダーは成功の度合いが異なる4つの象限に分類されます：フォアフロント（F）、パスファインダー（P）、ニッチ（N）、バイタル（V）です。

市場シェア分析

市場シェア分析は、ホスホロアミダイト市場におけるベンダーの現状について、洞察に満ちた詳細な調査を提供する包括的なツールです。全体的な収益、顧客基盤、その他の主要指標についてベンダーの貢献度を綿密に比較・分析することで、企業の業績や市場シェア争いの際に直面する課題について理解を深めることができます。さらに、この分析により、調査対象基準年に観察された累積、断片化の優位性、合併の特徴などの要因を含む、この分野の競合特性に関する貴重な考察が得られます。このような詳細レベルの拡大により、ベンダーはより多くの情報に基づいた意思決定を行い、市場で競争優位に立つための効果的な戦略を考案することができます。

本レポートは、以下の側面に関する貴重な洞察を提供しています：

1-市場の浸透度：主要企業が提供する市場に関する包括的な情報を提示しています。

2-市場の開拓度：有利な新興市場を深く掘り下げ、成熟市場セグメントにおける浸透度を分析しています。

3-市場の多様化：新製品の発売、未開拓の地域、最近の開発、投資に関する詳細な情報を提供します。

4-競合の評価と情報：市場シェア、戦略、製品、認証、規制状況、特許状況、主要企業の製造能力などを網羅的に評価します。

5-製品開発およびイノベーション：将来の技術、研究開発活動、画期的な製品開発に関する知的洞察を提供します。

本レポートは、以下のような主要な質問に対応しています：

1-ホスホロアミダイト市場の市場規模および予測は？

2-ホスホロアミダイト市場の予測期間中に投資を検討すべき製品、セグメント、用途、分野は何か？

3-ホスホロアミダイト市場における技術動向と規制の枠組みは？

4-ホスホロアミダイト市場における主要ベンダーの市場シェアは？

5-ホスホロアミダイト市場への参入に適した形態や戦略的手段は？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

  • 市場力学
    • 促進要因
      • 遺伝子調査、診断、治療、バイオテクノロジーにおけるオリゴヌクレオチドの需要の増大
      • 配列決定技術の出現によるゲノミクス調査の継続的な進歩
      • 製薬・バイオテクノロジー産業の拡大
    • 抑制要因
      • ホスホロアミダイト合成の高コストとスケーラビリティの問題
    • 機会
      • ホスホラミダイトの合成方法と技術の継続的な進歩
      • 個別化医療の進歩による高い可能性
    • 課題
      • ホスホロアミダイト合成に関連する環境および安全上の懸念
  • 市場セグメンテーション分析
  • 市場動向分析
  • 高インフレの累積的影響
  • ポーターのファイブフォース分析
  • バリューチェーンとクリティカルパス分析
  • 規制の枠組み

第6章 ホスホロアミダイト市場：タイプ別

  • DNAホスホルアミダイト
  • 色素標識ホスホルアミダイト
  • RNAホスホルアミダイト
  • 特殊ホスホルアミダイト

第7章 ホスホロアミダイト市場：エンドユーザー別

  • 学術・調査機関
  • 受託調査機関
  • 製薬およびバイオテクノロジー

第8章 南北アメリカのホスホロアミダイト市場

  • アルゼンチン
  • ブラジル
  • カナダ
  • メキシコ
  • 米国

第9章 アジア太平洋地域のホスホロアミダイト市場

  • オーストラリア
  • 中国
  • インド
  • インドネシア
  • 日本
  • マレーシア
  • フィリピン
  • シンガポール
  • 韓国
  • 台湾
  • タイ
  • ベトナム

第10章 欧州・中東・アフリカのホスホロアミダイト市場

  • デンマーク
  • エジプト
  • フィンランド
  • フランス
  • ドイツ
  • イスラエル
  • イタリア
  • オランダ
  • ナイジェリア
  • ノルウェー
  • ポーランド
  • カタール
  • ロシア
  • サウジアラビア
  • 南アフリカ
  • スペイン
  • スウェーデン
  • スイス
  • トルコ
  • アラブ首長国連邦
  • 英国

第11章 競合情勢

  • FPNVポジショニングマトリクス
  • 市場シェア分析：主要企業別
  • 競合シナリオ主要企業別の分析
    • 契約、コラボレーション、パートナーシップ

第12章 競争力のあるポートフォリオ

  • 主要な企業プロファイル
    • AAT Bioquest, Inc.
    • Actylis
    • Amadis Chemical Company Limited
    • American International Chemical, LLC
    • Bioneer Corporation
    • Biosynth Ltd.
    • BOCSCI Inc.
    • ChemGenes Corporation
    • Creative Biolabs
    • Hongene Biotech Corporation
    • Huaren Science and Technology Co., Ltd.
    • Integrated DNA Technologies, Inc. by Danaher Corporation
    • LGC Limited
    • Lumiprobe Corporation
    • Maravai LifeSciences
    • MedChemExpress
    • Merck KGaA
    • PolyOrg, Inc.
    • QIAGEN N.V.
    • SBS Genetech Co., Ltd.
    • STA Pharmaceutical Co. Ltd. by WuXi AppTec Co., Ltd.
    • Thermo Fisher Scientific Inc.
    • Tokyo Chemical Industry Co., Ltd.
    • Twist Bioscience Corporation
  • 主要な製品ポートフォリオ

第13章 付録

  • ディスカッションガイド
  • ライセンスと価格について
図表

LIST OF FIGURES

  • FIGURE 1. PHOSPHORAMIDITE MARKET RESEARCH PROCESS
  • FIGURE 2. PHOSPHORAMIDITE MARKET SIZE, 2023 VS 2030
  • FIGURE 3. PHOSPHORAMIDITE MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. PHOSPHORAMIDITE MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. PHOSPHORAMIDITE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. PHOSPHORAMIDITE MARKET DYNAMICS
  • FIGURE 7. PHOSPHORAMIDITE MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 8. PHOSPHORAMIDITE MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. PHOSPHORAMIDITE MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 10. PHOSPHORAMIDITE MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. AMERICAS PHOSPHORAMIDITE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 12. AMERICAS PHOSPHORAMIDITE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. UNITED STATES PHOSPHORAMIDITE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 14. UNITED STATES PHOSPHORAMIDITE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. ASIA-PACIFIC PHOSPHORAMIDITE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 16. ASIA-PACIFIC PHOSPHORAMIDITE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA PHOSPHORAMIDITE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA PHOSPHORAMIDITE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. PHOSPHORAMIDITE MARKET, FPNV POSITIONING MATRIX, 2023
  • FIGURE 20. PHOSPHORAMIDITE MARKET SHARE, BY KEY PLAYER, 2023

LIST OF TABLES

  • TABLE 1. PHOSPHORAMIDITE MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. PHOSPHORAMIDITE MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL PHOSPHORAMIDITE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. PHOSPHORAMIDITE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 6. PHOSPHORAMIDITE MARKET SIZE, BY DNA PHOSPHORAMIDITES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. PHOSPHORAMIDITE MARKET SIZE, BY DYE-LABELED PHOSPHORAMIDITES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. PHOSPHORAMIDITE MARKET SIZE, BY RNA PHOSPHORAMIDITES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. PHOSPHORAMIDITE MARKET SIZE, BY SPECIALITY PHOSPHORAMIDITES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. PHOSPHORAMIDITE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 11. PHOSPHORAMIDITE MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. PHOSPHORAMIDITE MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. PHOSPHORAMIDITE MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. AMERICAS PHOSPHORAMIDITE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 15. AMERICAS PHOSPHORAMIDITE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 16. AMERICAS PHOSPHORAMIDITE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 17. ARGENTINA PHOSPHORAMIDITE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 18. ARGENTINA PHOSPHORAMIDITE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 19. BRAZIL PHOSPHORAMIDITE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 20. BRAZIL PHOSPHORAMIDITE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 21. CANADA PHOSPHORAMIDITE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 22. CANADA PHOSPHORAMIDITE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 23. MEXICO PHOSPHORAMIDITE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 24. MEXICO PHOSPHORAMIDITE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 25. UNITED STATES PHOSPHORAMIDITE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 26. UNITED STATES PHOSPHORAMIDITE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 27. UNITED STATES PHOSPHORAMIDITE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 28. ASIA-PACIFIC PHOSPHORAMIDITE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 29. ASIA-PACIFIC PHOSPHORAMIDITE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 30. ASIA-PACIFIC PHOSPHORAMIDITE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 31. AUSTRALIA PHOSPHORAMIDITE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 32. AUSTRALIA PHOSPHORAMIDITE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 33. CHINA PHOSPHORAMIDITE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 34. CHINA PHOSPHORAMIDITE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 35. INDIA PHOSPHORAMIDITE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 36. INDIA PHOSPHORAMIDITE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 37. INDONESIA PHOSPHORAMIDITE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 38. INDONESIA PHOSPHORAMIDITE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 39. JAPAN PHOSPHORAMIDITE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 40. JAPAN PHOSPHORAMIDITE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 41. MALAYSIA PHOSPHORAMIDITE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 42. MALAYSIA PHOSPHORAMIDITE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 43. PHILIPPINES PHOSPHORAMIDITE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 44. PHILIPPINES PHOSPHORAMIDITE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 45. SINGAPORE PHOSPHORAMIDITE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 46. SINGAPORE PHOSPHORAMIDITE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 47. SOUTH KOREA PHOSPHORAMIDITE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 48. SOUTH KOREA PHOSPHORAMIDITE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 49. TAIWAN PHOSPHORAMIDITE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 50. TAIWAN PHOSPHORAMIDITE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 51. THAILAND PHOSPHORAMIDITE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 52. THAILAND PHOSPHORAMIDITE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 53. VIETNAM PHOSPHORAMIDITE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 54. VIETNAM PHOSPHORAMIDITE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 55. EUROPE, MIDDLE EAST & AFRICA PHOSPHORAMIDITE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 56. EUROPE, MIDDLE EAST & AFRICA PHOSPHORAMIDITE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 57. EUROPE, MIDDLE EAST & AFRICA PHOSPHORAMIDITE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 58. DENMARK PHOSPHORAMIDITE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 59. DENMARK PHOSPHORAMIDITE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 60. EGYPT PHOSPHORAMIDITE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 61. EGYPT PHOSPHORAMIDITE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 62. FINLAND PHOSPHORAMIDITE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 63. FINLAND PHOSPHORAMIDITE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 64. FRANCE PHOSPHORAMIDITE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 65. FRANCE PHOSPHORAMIDITE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 66. GERMANY PHOSPHORAMIDITE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. GERMANY PHOSPHORAMIDITE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 68. ISRAEL PHOSPHORAMIDITE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. ISRAEL PHOSPHORAMIDITE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 70. ITALY PHOSPHORAMIDITE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 71. ITALY PHOSPHORAMIDITE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 72. NETHERLANDS PHOSPHORAMIDITE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. NETHERLANDS PHOSPHORAMIDITE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 74. NIGERIA PHOSPHORAMIDITE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. NIGERIA PHOSPHORAMIDITE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 76. NORWAY PHOSPHORAMIDITE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 77. NORWAY PHOSPHORAMIDITE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 78. POLAND PHOSPHORAMIDITE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. POLAND PHOSPHORAMIDITE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 80. QATAR PHOSPHORAMIDITE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 81. QATAR PHOSPHORAMIDITE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 82. RUSSIA PHOSPHORAMIDITE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. RUSSIA PHOSPHORAMIDITE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 84. SAUDI ARABIA PHOSPHORAMIDITE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 85. SAUDI ARABIA PHOSPHORAMIDITE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 86. SOUTH AFRICA PHOSPHORAMIDITE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 87. SOUTH AFRICA PHOSPHORAMIDITE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 88. SPAIN PHOSPHORAMIDITE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. SPAIN PHOSPHORAMIDITE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 90. SWEDEN PHOSPHORAMIDITE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. SWEDEN PHOSPHORAMIDITE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 92. SWITZERLAND PHOSPHORAMIDITE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. SWITZERLAND PHOSPHORAMIDITE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 94. TURKEY PHOSPHORAMIDITE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. TURKEY PHOSPHORAMIDITE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 96. UNITED ARAB EMIRATES PHOSPHORAMIDITE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 97. UNITED ARAB EMIRATES PHOSPHORAMIDITE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 98. UNITED KINGDOM PHOSPHORAMIDITE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. UNITED KINGDOM PHOSPHORAMIDITE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 100. PHOSPHORAMIDITE MARKET, FPNV POSITIONING MATRIX, 2023
  • TABLE 101. PHOSPHORAMIDITE MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 102. PHOSPHORAMIDITE MARKET LICENSE & PRICING
目次
Product Code: MRR-EA74537D7BA3

[190 Pages Report] The Phosphoramidite Market size was estimated at USD 1.28 billion in 2023 and expected to reach USD 1.38 billion in 2024, at a CAGR 7.49% to reach USD 2.13 billion by 2030.

Global Phosphoramidite Market

KEY MARKET STATISTICS
Base Year [2023] USD 1.28 billion
Estimated Year [2024] USD 1.38 billion
Forecast Year [2030] USD 2.13 billion
CAGR (%) 7.49%
Phosphoramidite Market - IMG1

Phosphoramidite is a class of compounds commonly used to synthesize nucleic acids, such as DNA and RNA, during solid-phase oligonucleotide synthesis. Phosphoramidites are organic phosphorus compounds that contain a phosphorus atom bonded to an amino group through a nitrogen atom and various protecting groups to control reactivity. Growing genomics research activities with the advent of high-throughput sequencing technologies and the need for studying genetic information on a large scale are expanding the usage of phosphoramidite. Increasing focus on personalized medicine that aims to provide tailored healthcare solutions based on an individual's genetic makeup elevates the demand for phosphoramidite. High cost and scalability associated with phosphoramidite hampers market growth. Continuous advancements in synthesis methods and phosphoramidite techniques present opportunities for improvement in efficiency, yield, and cost-effectiveness.

Regional Insights

The presence of well-established pharmaceutical and biotechnology industries, particularly in the United States and Canada, drives the demand for phosphoramidites as essential building blocks in synthesizing nucleic acid-based therapeutics and research tools. Regulatory agencies, including the FDA in the United States, provide guidelines and support for the development of nucleic acid-based therapeutics, which facilitates the adoption of phosphoramidites in the region and encourages market growth. Increasing personalized medicine initiatives, which aim to provide tailored healthcare solutions based on an individual's genetic information, is expected to create opportunities for phosphoramidite manufacturers in the EMEA market. Governments in the Asia-Pacific region actively support the development of their biotechnology and life sciences sectors through various initiatives and funding programs. For instance, China has launched the "Made in China 2025" initiative to promote the development of advanced manufacturing, including biotechnology. Government support and funding facilitate research and development activities, creating opportunities for phosphoramidite manufacturers to collaborate and contribute to the market's growth.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Phosphoramidite Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Phosphoramidite Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Phosphoramidite Market, highlighting leading vendors and their innovative profiles. These include AAT Bioquest, Inc., Actylis, Amadis Chemical Company Limited, American International Chemical, LLC, Bioneer Corporation, Biosynth Ltd., BOCSCI Inc., ChemGenes Corporation, Creative Biolabs, Hongene Biotech Corporation, Huaren Science and Technology Co., Ltd., Integrated DNA Technologies, Inc. by Danaher Corporation, LGC Limited, Lumiprobe Corporation, Maravai LifeSciences, MedChemExpress, Merck KGaA, PolyOrg, Inc., QIAGEN N.V., SBS Genetech Co., Ltd., STA Pharmaceutical Co. Ltd. by WuXi AppTec Co., Ltd., Thermo Fisher Scientific Inc., Tokyo Chemical Industry Co., Ltd., and Twist Bioscience Corporation.

Market Segmentation & Coverage

This research report categorizes the Phosphoramidite Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Type
    • DNA Phosphoramidites
    • Dye-Labeled Phosphoramidites
    • RNA Phosphoramidites
    • Speciality Phosphoramidites
  • End-User
    • Academic & Research Institutions
    • Contract Research Organizations
    • Pharmaceutical & Biotechnology
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Phosphoramidite Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Phosphoramidite Market?

3. What are the technology trends and regulatory frameworks in the Phosphoramidite Market?

4. What is the market share of the leading vendors in the Phosphoramidite Market?

5. Which modes and strategic moves are suitable for entering the Phosphoramidite Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Phosphoramidite Market, by Region

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing demand for oligonucleotides in genetic research, diagnostics, therapeutics, and biotechnology
      • 5.1.1.2. Continuous advancements in genomics research with the advent of sequencing technologies
      • 5.1.1.3. Expansion of the pharmaceutical and biotechnology industries
    • 5.1.2. Restraints
      • 5.1.2.1. High cost and scalability issues with phosphoramidite synthesis
    • 5.1.3. Opportunities
      • 5.1.3.1. Continuous advancements in synthesis methods and techniques for phosphoramidites
      • 5.1.3.2. High potential owing to rising advancements in personalized medicine
    • 5.1.4. Challenges
      • 5.1.4.1. Environmental and safety concerns associated with phosphoramidite synthesis
  • 5.2. Market Segmentation Analysis
  • 5.3. Market Trend Analysis
  • 5.4. Cumulative Impact of High Inflation
  • 5.5. Porter's Five Forces Analysis
    • 5.5.1. Threat of New Entrants
    • 5.5.2. Threat of Substitutes
    • 5.5.3. Bargaining Power of Customers
    • 5.5.4. Bargaining Power of Suppliers
    • 5.5.5. Industry Rivalry
  • 5.6. Value Chain & Critical Path Analysis
  • 5.7. Regulatory Framework

6. Phosphoramidite Market, by Type

  • 6.1. Introduction
  • 6.2. DNA Phosphoramidites
  • 6.3. Dye-Labeled Phosphoramidites
  • 6.4. RNA Phosphoramidites
  • 6.5. Speciality Phosphoramidites

7. Phosphoramidite Market, by End-User

  • 7.1. Introduction
  • 7.2. Academic & Research Institutions
  • 7.3. Contract Research Organizations
  • 7.4. Pharmaceutical & Biotechnology

8. Americas Phosphoramidite Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Phosphoramidite Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Phosphoramidite Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. FPNV Positioning Matrix
  • 11.2. Market Share Analysis, By Key Player
  • 11.3. Competitive Scenario Analysis, By Key Player
    • 11.3.1. Agreement, Collaboration, & Partnership
      • 11.3.1.1. Innovassynth and Actylis partner to address Nucleic Acid Supply Chain Vulnerabilities

12. Competitive Portfolio

  • 12.1. Key Company Profiles
    • 12.1.1. AAT Bioquest, Inc.
    • 12.1.2. Actylis
    • 12.1.3. Amadis Chemical Company Limited
    • 12.1.4. American International Chemical, LLC
    • 12.1.5. Bioneer Corporation
    • 12.1.6. Biosynth Ltd.
    • 12.1.7. BOCSCI Inc.
    • 12.1.8. ChemGenes Corporation
    • 12.1.9. Creative Biolabs
    • 12.1.10. Hongene Biotech Corporation
    • 12.1.11. Huaren Science and Technology Co., Ltd.
    • 12.1.12. Integrated DNA Technologies, Inc. by Danaher Corporation
    • 12.1.13. LGC Limited
    • 12.1.14. Lumiprobe Corporation
    • 12.1.15. Maravai LifeSciences
    • 12.1.16. MedChemExpress
    • 12.1.17. Merck KGaA
    • 12.1.18. PolyOrg, Inc.
    • 12.1.19. QIAGEN N.V.
    • 12.1.20. SBS Genetech Co., Ltd.
    • 12.1.21. STA Pharmaceutical Co. Ltd. by WuXi AppTec Co., Ltd.
    • 12.1.22. Thermo Fisher Scientific Inc.
    • 12.1.23. Tokyo Chemical Industry Co., Ltd.
    • 12.1.24. Twist Bioscience Corporation
  • 12.2. Key Product Portfolio

13. Appendix

  • 13.1. Discussion Guide
  • 13.2. License & Pricing